Serum progranulin levels in relation to insulin resistance in childhood obesity

Insights

Elevated serum progranulin levels in children are linked to increased adiposity, insulin resistance, and inflammation. Progranulin may serve as a valuable biomarker for childhood obesity and associated metabolic disturbances.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Syndrome Research
  • Adipokine Signaling

Background:

  • Progranulin, an adipokine, influences inflammation, glucose metabolism, and insulin resistance.
  • Childhood obesity is associated with chronic subclinical inflammation.
  • Progranulin's role in childhood obesity pathogenesis warrants investigation.

Purpose of the Study:

  • To investigate the association between circulating progranulin levels and metabolic parameters in children.
  • To evaluate progranulin as a potential biomarker for metabolic diseases in pediatric populations.

Main Methods:

  • 150 children were recruited from pediatric nutrition clinics.
  • Children were stratified into four groups based on serum progranulin quartiles.
  • Anthropometric measurements, fasting glucose, insulin, and lipid profiles were assessed.

Main Results:

  • Children in the highest progranulin quartile exhibited greater adiposity, insulin resistance, and elevated lipids and C-reactive protein.
  • Serum progranulin correlated significantly with adiposity, metabolic parameters, inflammation, and insulin resistance markers.
  • Adiposity measures explained 26.6% of the variability in serum progranulin levels.

Conclusions:

  • Increased serum progranulin concentrations are closely associated with adiposity, metabolic parameters, and insulin resistance in children.
  • Progranulin shows potential as an excellent biomarker for identifying childhood obesity.
  • Further research can explore progranulin's therapeutic implications in pediatric metabolic health.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
864
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.1K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.0K